Structure of Ceralasertib
CAS No.: 1352226-88-0
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Ceralasertib (AZD6738) is an orally active and bioavailable ATR kinase inhibitor with an IC50 of 1 nM.
Synonyms: AZD6738
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 1352226-88-0 |
Formula : | C20H24N6O2S |
M.W : | 412.51 |
SMILES Code : | N=[S@]([C@H]1C(C2=CC(N3[C@H](C)COCC3)=NC(C4=C5C(NC=C5)=NC=C4)=N2)C1)(C)=O |
Synonyms : |
AZD6738
|
MDL No. : | MFCD28952790 |
InChI Key : | OHUHVTCQTUDPIJ-JYCIKRDWSA-N |
Pubchem ID : | 54761306 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H319-H335 |
Precautionary Statements: | P261-P305+P351+P338 |
Target |
|
In Vitro:
Cell Line
|
Concentration | Treated Time | Description | References |
FaDu ATM-KO cells | 1 μM | 24 h | Induced cell death | PMC7299845 |
ATM-proficient mouse embryonic stem cells | 350 nM | 6 days | To assess the sensitivity of ATM-proficient cells to Ceralasertib | PMC8421211 |
ATM-deficient mouse embryonic stem cells | 100 nM | 6 days | To assess the sensitivity of ATM-deficient cells to Ceralasertib | PMC8421211 |
CD3/CD28 stimulated T-cells | 1 μM | 4 days | To evaluate the effect of Ceralasertib on T-cell proliferation, the results showed that Ceralasertib significantly increased the expression of DNA damage markers. | PMC10894296 |
IMR-5 | 0.05 μM | 48 h | To study the DNA damage effects of CX-5461 on neuroblastoma cells, results showed that CX-5461 induced DNA damage at low concentrations. | PMC8578635 |
CHP-134 | 0.04 μM | 3 days | To study the cytotoxicity of CX-5461 on neuroblastoma cells, results showed that CX-5461 effectively induced apoptosis at low concentrations. | PMC8578635 |
HEK293 cells | >0.333 μM | 24 h | To evaluate the inhibitory effect of Ceralasertib on HRR, results showed that Ceralasertib could inhibit HRR | PMC9359726 |
A549 cells | >0.333 μM | 72 h | To evaluate the inhibitory effect of Ceralasertib on BIR repair, results showed that Ceralasertib could inhibit BIR repair | PMC9359726 |
FaDu WT and FaDu ATM −/− cells | 1 µM | 24, 48, 72 h | Investigated the sensitivity of ATM-deficient cells to Ceralasertib, showing that ATM −/− cells exhibited higher DNA damage, early apoptosis, and cell death after Ceralasertib treatment. | PMC9481087 |
LL2-luc cells | 1 µM | 1 h | To evaluate the effect of AZD6738 on the radiosensitivity of LL2-luc cells, results showed that AZD6738 enhanced the radiosensitivity of the cells. | PMC7463250 |
LL2-luc cells | 0.6 µM | 72 h | To evaluate the effect of AZD6738 on the proliferation of LL2-luc cells, results showed that AZD6738 has anti-proliferative effects. | PMC7463250 |
HPAF-II | 2000 nM | 24 h | To evaluate the effect of ATR inhibitor AZD6738 in combination with gemcitabine on DDR signaling pathways, results showed that DNA-PK-driven phosphorylation of Chk1 and Chk2 persisted. | PMC7591912 |
MIA PaCa-2 | 500 nM | 24 h | To evaluate the effect of ATR inhibitor AZD6738 on the cell cycle, results showed that ATM-deficient cells exhibited increased intra-S phase accumulation and induced cell death. | PMC7591912 |
MiaPaCa-2 cells | 2 µM | 24 h | AZD6738 in combination with gemcitabine significantly induced phosphorylation of pRPA and γH2AX, indicating a strong induction of replication stress in these cells | PMC6076438 |
K8484 cells | 2 µM | 7 h | AZD6738 completely prevented gemcitabine-induced Chk1 phosphorylation and restored Cdk1 activity | PMC6076438 |
In Vivo:
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
Mice | CT26, MC38, 4T1, and A20 tumor models | Oral | 25 mg/kg | Twice daily, 7 days on/7 days off | To evaluate the antitumor effect of Ceralasertib under an intermittent dosing schedule, the results showed that Ceralasertib significantly inhibited tumor growth, and its antitumor effect was dependent on CD8+ T cells. | PMC10894296 |
Mice | Neuroblastoma xenograft model | Intraperitoneal injection | 5 mg/kg | Once daily for 5 days, starting a second 5-day course on day 8, repeated every 21 days | To study the anti-tumor activity of CX-5461 in vivo, results showed that CX-5461 significantly improved survival when combined with TOP1 inhibitors in orthotopic PDX mouse models. | PMC8578635 |
Nude mice | Granta-519 mantle cell lymphoma model | Oral | 50 mg/kg | Once daily for 21 days | To evaluate the antitumor activity of Ceralasertib in vivo, results showed significant tumor growth inhibition at 50 mg/kg dose | PMC9359726 |
Mice | Subcutaneous and orthotopic LL2-luc tumour models | Intraperitoneal injection | 15 mg/kg | Daily for 6 days | To evaluate the antitumor efficacy of AZD6738 in combination with radiotherapy in subcutaneous and orthotopic LL2-luc tumour models, results showed that AZD6738 enhanced the antitumor efficacy of radiotherapy, but the effect was limited in orthotopic tumour models. | PMC7463250 |
Mice | MIA PaCa-2 subcutaneous xenograft model | Oral | 50 mg/kg | Once daily for 5 consecutive days a week for 3 weeks | To evaluate the efficacy of ATR inhibitor AZD6738 monotherapy in ATM-deficient xenografts, results showed significant growth delay in ATM-deficient tumors. | PMC7591912 |
Mice | K8484 subcutaneous allograft model | Oral | 25 mg/kg | 5 days/week for 3 weeks | AZD6738 in combination with gemcitabine significantly inhibited tumor growth and extended survival in mice | PMC6076438 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT03770429 | Leukemia|Myelodysplastic Syndr... More >>ome Less << | PHASE1 | RECRUITING | 2025-05-31 | BIDMC, Boston, Massachusetts, ... More >>02215, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Massachusetts General Hospital Cancer Center, Boston, Massachusetts, 02215, United States|Washington University, Saint Louis, Missouri, 63110, United States Less << |
NCT05469919 | Advanced Solid Malignancies | PHASE1 | COMPLETED | 2024-03-12 | Research Site, Chuo-ku, 104-00... More >>45, Japan Less << |
NCT04564027 | Advanced Solid Tumours | PHASE2 | ACTIVE_NOT_RECRUITING | 2025-02-07 | Research Site, Duarte, Califor... More >>nia, 91010, United States|Research Site, Los Angeles, California, 90089, United States|Research Site, San Francisco, California, 94115, United States|Research Site, Tampa, Florida, 33612, United States|Research Site, Indianapolis, Indiana, 46202, United States|Research Site, Baltimore, Maryland, 21231, United States|Research Site, Ann Arbor, Michigan, 48109, United States|Research Site, Las Vegas, Nevada, 89119, United States|Research Site, New York, New York, 10065, United States|Research Site, Ephrata, Pennsylvania, 17522, United States|Research Site, Philadelphia, Pennsylvania, 19104, United States|Research Site, Myrtle Beach, South Carolina, 29572, United States|Research Site, Bordeaux, 33076, France|Research Site, Dijon, 21079, France|Research Site, Lyon, 69373, France|Research Site, Vandoeuvre les Nancy, 54519, France|Research Site, Barcelona, 08036, Spain|Research Site, Madrid, 28050, Spain Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.42mL 0.48mL 0.24mL |
12.12mL 2.42mL 1.21mL |
24.24mL 4.85mL 2.42mL |
Tags: Ceralasertib | AZD6738 | AZD 6738 | AZD-6738 | ATM/ATR | Ataxia telangiectasia mutated | ATR kinase inhibitor | DNA damage response | Ataxia Telangiectasia and Rad3-related protein | 1352226-88-0
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL